Miura Partners backs Saesco Medical, a European key player in medical devices and equipment distribution for minimally invasive surgery
- Saesco Medical, present in five European countries, specialises in highly innovative solutions for advanced surgical procedures in obesity, gynaecology, urology and general surgery.
- The partnership includes the acquisition of Cardiolink, a specialist in the distribution of products and devices for general surgery, endoscopy, organ preservation, cardiology, urology and gynaecology.
Miura Partners has partnered with Saesco Medical, a European group specialised in the distribution of medical devices and consumables for minimally invasive surgery.
The transaction also includes the acquisition of Cardiolink, a company founded in 2004 by Josep Gatell and Manuel Vidal, recognised as a key player in implementing medical technologies in Spain and Portugal. Cardiolink joins the Saesco group to strengthen its presence in the clinical and hospital sector in Iberia and expand its therapeutic portfolio.
Founded in 2009 in Barcelona by the Saenger Escolà family and Jordi Fluvià, Saesco is a recognised player in the implementation, training, and commercial development of innovative medical technologies, primarily focused on surgical areas such as obesity, gynaecology, urology and general surgery. The company has expanded into a multi-vertical platform, operating directly in Spain, Belgium, the Netherlands, Italy and Poland, and is commercially active across key European markets.
Its portfolio includes over 600 products distributed exclusively on behalf of leading international manufacturers. Saesco serves more than 2,000 public and private healthcare providers across Europe, supplying both large hospitals and specialised clinics.
Since 2019, Saesco has completed six integrations across Europe, reinforcing its leadership as a pan-European distributor of medical technologies. Miura’s investment, via a capital increase, supports Saesco’s international growth and consolidation strategy.
Cardiolink brings highly complementary strengths in product offering, distribution channels, and client base, with a strong presence in Spain’s public hospital network. Its operations focus on key divisions such as cardiology, general surgery, endoscopy, organ preservation and intensive care, significantly enhancing Saesco’s therapeutic scope.
Following the transaction, the group achieves a combined turnover of over €50 million, positioning itself as a reference player in the European medical device distribution sector.
Jordi Fluvià, CEO and founder of Saesco, will continue to lead the project. Together with Miura, he will focus on consolidating Saesco’s presence in existing geographies and therapeutic areas, while driving international expansion into new key European regions. The growth strategy will combine organic initiatives — such as product portfolio expansion and deeper commercial footprint with Cardiolink — with selective acquisitions, maintaining innovation and minimally invasive surgery as core pillars.
Carlos Julià, partner at Miura Partners:
“We are very pleased to partner with Saesco, a company with a strong position in medical technology and a clear focus on key therapeutic areas critical to modern medicine. Our experience scaling and consolidating healthcare businesses across Europe, combined with a highly committed management team and a distinctive value proposition, gives us great confidence for this next stage.”
Jordi Fluvià, CEO of Saesco:
“Miura’s entry and the integration of Cardiolink significantly strengthen our capacity for sustainable and strategic growth. We share a common vision of innovation and quality, and we believe this alliance will be key to continuing to deliver high-value solutions to healthcare providers across Europe.”
The transaction was advised by Aquilon Partners and AZ Capital (Finance); Cuatrecasas and Deloitte (Legal); and Roland Berger (Commercial). The transaction is subject to regulatory approval.
About Miura Partners
Miura Partners is a purpose-driven Private Equity firm. With offices in Barcelona and Madrid, the firm specializes in investing in small and medium-sized family-owned and entrepreneurial companies. Miura provides attractive growth and innovation plans with a clear focus on sustainability and internationalisation.
Since inception in 2008, Miura has raised five primary funds across its Buyout and Impact strategies, alongside two continuation vehicles in the Agribusiness and Dental Health verticals. The firm currently manages assets exceeding €1.5bn and has completed more than 80 investments worth in excess of €4bn.
About Saesco Medical
Saesco Medical is a European distributor specialised in innovative consumables for minimally invasive surgical procedures, with a strong focus on therapeutic areas such as obesity, gynaecology, urology, and general surgery. Founded in 2009 in Barcelona, the company employs more than 50 professionals and operates under exclusive distribution agreements with leading international manufacturers. With direct operations in five countries and commercial activity across multiple European markets, Saesco serves over 2,000 clients and manages a portfolio of more than 600 products, positioning itself as a reference platform in the European medical technology sector.
About Cardiolink
Cardiolink is a Spanish company dedicated to distribution of highly specialised and innovative medical devices. Founded in 2004 in Barcelona, it has established itself as a reference player in the medical technology sector, offering high-quality solutions in areas such as cardiac surgery, general surgery, interventional cardiology, intensive care, interventional radiology, endoscopy, gynaecology, urology, and organ preservation for transplantation. With a dedicated commercial network and an active presence across numerous hospitals and healthcare centres, Cardiolink continues its growth trajectory, consolidating its role as a strategic partner in healthcare innovation across Europe.
